| HOME >> BIOLOGY >> TECHNOLOGY |
ULURU will be exhibiting Altrazeal(TM) at their booth during SAWC, demonstrating its unique mechanism of action and ease of application for wound care professionals in attendance.
Details of SAWC are available online at http://www.sawc.net
About ULURU Inc.:
ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex(TM) Aggregate technology and OraDisc(TM) transmucosal delivery system. For further information about ULURU, please visit our website at www.uluruinc.com. For further information about Altrazeal(TM), please visit our website at www.altrazeal.com.
This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to the benefits, effectiveness, biocompatibility, patient comfort, ease of application, success in wound healing, and suitability of Altrazeal(TM) and Altrazeal(TM) Silver, and the success of our clinical efforts. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2008, and other reports filed by us with the Securities and Exchange Commission.
Contact: Company
Renaat Van den Hooff
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145
| SOURCE ULURU Inc. Copyright©2009 PR Newswire. All rights reserved |